Skip to main content
OpenTrials
Completed

NCT Number: NCT04222907

The Relationship Between GBS Screening in Pregnant Women Insured in Maccabi Healthcare Services (MHS) and Early-onset Neonatal Disease in Israel

Determination of GBS colonization rates in Pregnant Women insured with Maccabi Health Services, Doctors' Compliance Rates for Referral for Testing, test execution rates, and Early-onset GBS Disease (EOGBSD) Rates in Israel. Determine the relationship between conducting a GBS test in pregnant women and EOGBSD in Israel.

Completed

Looking for future studies?

Notify Me

Key information

About this study

There have been few studies in recent years, which has prompted us to undertake this study. Our aim was to examine the current colonization rates and attack rates in the Israeli population. Our secondary aim was to evaluate the need to readjust recommendations towards universal screening.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All women with term pregnancies from 2015 to 2016 (until 20/9/16) insured by Maccabi Healthcare Services (MHS)

Exclusion criteria

  • repeat pregnancies occurring in the same woman during the time period
  • multiple pregnancies
  • gestational age greater than 42 weeks due to probability of data inaccuracy
  • women with missing information

Treatment and study plan

Primary outcomes

  1. Attack rate of early-onset GBS disease (EOGBSD)

    Time frame: 2015-2016

    Attack rate of (EOGBSD)

Sponsors and collaborators

Lead sponsor

Assuta Hospital Systems

Other

Registry information

Important dates

Study start
2015
Primary completion
2016
Study completion
2019
First posted
Jan 10, 2020
Registry last updated
Jan 13, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.